Abstract-Plantar fasciitis (PFS) is one of the most common causes of heel pain, estimated to affect 10% of the general population during their lifetime. Ultrasound (US) imaging technique is increasingly being used to assess plantar fascia (PF) thickness, monitor the effect of different interventions and guide therapeutic interventions in patients with PFS. The purpose of the present study was to systematically review previously published studies concerning the application of US in the assessment of PF in patients with PFS. A literature search was performed for the period 2000-2012 using the Science Direct, Scopus, PubMed, CINAHL, Medline, Embase and Springer databases. The key words used were: ultrasound, sonography, imaging techniques, ultrasonography, interventional ultrasonography, plantar fascia and plantar fasciitis. The literature search yielded 34 relevant studies. Sixteen studies evaluated the effect of different interventions on PF thickness in patients with PFS using US; 12 studies compared PF thickness between patients with and without PFS using US; 6 studies investigated the application of US as a guide for therapeutic intervention in patients with PFS. There were variations among studies in terms of methodology used. The results indicated that US can be considered a reliable imaging technique for assessing PF thickness, monitoring the effect of different interventions and guiding therapeutic interventions in patients with PFS.
INTRODUCTION
Plantar fascia (PF) is a thickened fibrous sheet of connective tissue that originates from the medial tubercle of the calcaneus and attaches to the plantar surface of the metatarsophalangeal joints. It acts as a static and dynamic stabilizer of the longitudinal arch of the foot and as a dynamic shock absorber (Hamblen and Simpson 2010; Oatis 2009 ). Plantar fasciitis (PFS) is the most common type of PF injury, estimated to affect 10% of the general population during middle age (Gordon et al. 2012; Urse 2012) ; also 8% of foot injuries in runners are related to PFS (Landorf et al. 2006 ). The main symptom of PFS is morning pain or pain at the beginning of activity after rest (Ragab and Othman 2012) , which may be worsen by the end of the day (Landorf et al. 2006) . Some studies have reported PFS is an inflammatory condition (Yucel et al. 2009 ), and some researchers have reported the hyaline degeneration of PF in PFS (Thomas et al. 2010) . The risk factors include biomechanical factors (e.g., excessive pronation, reduced ankle dorsiflexion), improper footwear, obesity and extensive standing, walking, and running (Gordon et al. 2012; Landorf et al. 2006; Thomas et al. 2010 ).
An appropriate physical examination is the main method for evaluating patients with PFS. Tenderness and pain may be increased by passive dorsiflexion of the toes or by having the patient stand on the tips of the toes. Tightness of the calf muscles, limited dorsiflexion of the ankle and tightness of the PF that restricts extension of the toes are other findings in the physical examination (Buchbinder 2004; Thomas et al. 2010; Young et al. 2001) .
Radiographic studies, as an objective method, play an important role in evaluation of PF in patients with and without PFS (Fabrikant and Park 2011) . For this purpose, the imaging techniques available are plain radiography, bone scan, magnetic resonance imaging (MRI) and ultrasound (US) (McMillan et al. 2009 ). Direct imaging of the PF is possible with MRI and US (McMillan et al. 2009 ). These methods have revealed that PF is thicker in patients with PFS than in those without PFS (Cheng et al. 2012; Wu et al. 2011) . Therefore, the changes in PF thickness after interventions in patients with PFS are measurable with imaging techniques. The advantages of US as compared with MRI are that it is non-invasive, it is radiation free, it is a cost-effective approach that is also well tolerated by patients and it is appropriate for serial follow-up (Fabrikant and Park 2011) .
Real-time US guidance is used to enhance the accuracy of such interventions as injections and extracorporeal shock wave therapy (ESWT) (Gordon et al. 2012; Kayhan et al. 2011; McMillan et al. 2012) . Injections made under US guidance can eliminate the risk of injection into the fat pad and thus prevent atrophy of the fat tissue, which in turn results in a reduced number of injections (Tsai et al. 2006) .
Many studies have investigated PF thickness in different patients and in different conditions using objective techniques. Real-time US imaging is one of the objective tools commonly used in the assessment of PF in many studies. The purpose of this study was to systematically review the previously published studies carried out on the merit of US in the assessment of PF and diagnosis of PFS and as a guide for therapeutic intervention in patients with PFS, with particular attention to its clinical application.
METHODS
A systematic review was conducted for the period 2000 to 2012 using the following databases: Medline, CINAHL, Embase, Science Direct, Scopus, PubMed, Springer. The guideline of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) was used (Liberati et al. 2009 ).
Search strategy
The key words used were: ultrasound, sonography, imaging techniques, ultrasonography, interventional ultrasonography, plantar fascia and plantar fasciitis. In addition, reference lists of the articles were also checked.
Inclusion criteria
The articles were included if they have met the following criteria: (i) the studies were carried out patients with PFS or healthy patients; (ii) US was applied in the assessment of PF; (iii) PF thickness was evaluated; (iv) the studies were published in the English language.
Study selection
Titles and abstracts were evaluated first by two reviewers; if the abstract or title was not clear, the entire article was checked. Articles were selected on the basis of the Critical Appraisal Skills Programme (CASP, CASP UK, Oxford, UK) checklist. The CASP results are summarized Table 1 . The third and fourth reviewers separately read a random sample of the articles. If there was no consensus, a consensus meeting was arranged to make the final decision.
The outcome of a study was identified as ''positive'' if the authors concluded that the US imaging can be used as an appropriate method for the assessment, diagnosis and as a therapeutic guide for intervention in patients with PFs. The outcome of a study was identified as ''negative'' if the authors concluded that the US imaging cannot be used as an appropriate method for the assessment, diagnosis and as a therapeutic guide for intervention in patients with PFs.
Data collection process
One hundred twenty-eight articles were identified by the search process. Thirty-four studies were relevant and included in this review. Sixteen of the 34 studies evaluated the effects of different interventions in patients with PFS using US imaging. In 12 studies the role of US in identifying changes in PF thickness in patients with PFS was compared with that in l patients without PFS. In 6 of the 34 studies, US was used as a guide for therapeutic interventions (Fig.1) .
RESULTS
Using the appropriate key words, 128 articles were identified by the database searching process; of these, 34 (Abdel-Wahab et al. 2008; Akfirat et al. 2003; Buchbinder et al. 2002; Cheng et al. 2012; Fabrikant and Park 2011; Folman et al. 2005; Genc et al. 2005; Gordon et al. 2012; Hammer et al. 2005; Huang et al. 2010; Hyer et al. 2005; Kamel and Kotob 2000; Kane et al. 2001; Kapoor et al. 2010; Karabay et al. 2007; Kayhan et al. 2011; Kiritsi et al. 2010; Mahowald et al. 2011; McMillan et al. 2012; Ozdemir et al. 2005; Ragab and Othman 2012; Ryan et al. 2009; Saber et al. 2012; Sabir et al. 2005; Theodore et al. 2004; Tsai et al. 2000a Tsai et al. , 2000b Tsai et al. , 2006 Vohra and Japour 2009; Vohra et al. 2002; Walther et al. 2004; Wearing et al. 2007; Wu et al. 2011; Yucel et al. 2009 ) studies were relevant and included in this review. Table 2 provides details on the studies investigating PFS using US from 2000 to 2012.
Sixteen of the 34 relevant studies (Fabrikant and Park 2011; Genc et al. 2005; Gordon et al. 2012; Hammer et al. 2005; Huang et al. 2010; Kamel and PF 5 plantar fascia; PFS 5 plantar fasciitis; US 5 ultrasonography; P 5 patients; H 5 healthy patients; F 5 feet; TT 5 tenderness threshold; VAS 5 visual analogue scale; HTI 5 heel tenderness index; ESWT 5 extracorporeal shock wave therapy; SF 5 The Short Form (36) Health Survey; PDU 5 Power Doppler ultrasonographic; MRI 5 magnetic resonance imaging; BMI 5 body mass index; AOFAS 5 American Orthopaedic Foot and Ankle Society; PG 5 palpation-guided; SG 5 scintigraphy-guided; LLLT 5 low-level laser therapy; VI 5 vascular index; EPAT 5 extracorporeal pulse-activated therapy; RPS 5 rated pain score; FSHQ 5 Foot Health Status Questionnaire; PRP 5 platelet-rich plasma; NA 5 not available; NR 5 not reported. Kotob 2000; Kane et al. 2001; Kayhan et al. 2011; Kiritsi et al. 2010; Mahowald et al. 2011; McMillan et al. 2012; Ragab and Othman 2012; Saber et al. 2012; Tsai et al. 2000b Tsai et al. , 2006 Yucel et al. 2009 ) evaluated the effects of different interventions on PF thickness in patients with PFS using US imaging. Table 3 provides details on the studies evaluating different interventions in patients with PFS using US. As outlined in Table 3 , in 9 of 16 studies, US was used as both a guide for therapeutic intervention and an assessment tool for evaluating PF thickness in patients with PFS. In the remaining 7studies, US was used as a tool for assessing PF thickness for evaluating the effects of interventions in patients with PFS only.
Twelve of 34 studies (Abdel-Wahab et al. 2008; Akfirat et al. 2003; Cheng et al. 2012; Kapoor et al. 2010; Karabay et al. 2007; Ozdemir et al. 2005; Sabir et al. 2005; Tsai et al. 2000a; Vohra et al. 2002; Walther et al. 2004; Wearing et al. 2007; Wu et al. 2011 ) investigated the role of US in identifying changes in PF thickness in patients with PFS as compared with patients without PFS. Details of studies are provided in Table 4 . As seen in Table 4 , in 4 of 12 studies, US was compared with other imaging methods for the evaluation of PF in patients with and without PFS. In 8 studies, US was just used as a tool for assessing PF thickness in patients with and without PFS and diagnosing PFS.
In 6 of the 34 studies (Buchbinder et al. 2002; Folman et al. 2005; Hyer et al. 2005; Ryan et al. 2009; Theodore et al. 2004; Vohra and Japour 2009) , US was used as a guide for therapeutic interventions. Details of these studies are provided in Table 5 . In 3 of these 6 studies, the effects of US guidance of ESWT were assessed; in 2 studies, US was used as a guide for surgery; and in one study, the effectiveness of US-guided injections was reported.
DISCUSSION
The purpose of this study was to systematically review published studies conducted in the assessment of PF in patients with and without PFS using US for the period 2000 to 2012. Thirty-four studies, carried out to assess PF thickness, monitor the effect of different interventions and guide therapeutic interventions in patients with PFS were reviewed. According to the results of this review, adequate evidence exists that ultrasound is a useful, reliable, less expensive, easier, faster and noninvasive imaging tool for assessing PF.
In all reviewed studies, the authors reported positive results in favor of US imaging in the assessment of PF thickness. There were many methodologic differences among studies. The most important variations were in sample size, duration of symptoms, inclusion criteria, types of US equipment, interventions used, measurement methods and follow-up duration. However, the results of this review support the use of US imaging in the assessment of PF thickness.
Evaluating PF thickness after different interventions
As indicated in Table 3 , 16 studies evaluated the use of US in different interventions such as injection, ESWT, low-level laser therapy (LLLT) and extracorporeal pulseactivated therapy (EPAT) in patients with PFS.
Six of 16 studies (Huang et al. 2010; Kamel and Kotob 2000; Kayhan et al. 2011; McMillan et al. 2012; Saber et al. 2012; Tsai et al. 2000b ) investigated the effect US-guided therapeutic injections in patients with PFS. All 6 studies reported a positive effect of the use of US for guided injection and evaluation of PF thickness before and after treatment. For example, in a randomized, double-blinded, placebo-controlled trial, McMillan et al. (2012) investigated the effectiveness of US-guided injection in the treatment of PFS in 82 patients. The primary outcomes measured were pain and PF thickness 4, 8 and 12 wk after injection. The authors concluded that a single US-guided injection is a tolerable and effective short-term treatment for PFS and provides greater pain relief than placebo at 4 wk and reduces abnormal swelling of the PF for up to 3 mo. Huang et al. (2010) evaluated the effectiveness of US-guided injections into the PF to reduce pain and improve gait in patients with unilateral PFS. Fifty patients with chronic unilateral PFS were recruited and divided into an experimental group and a control group. Pain and PF thickness in the symptomatic foot significantly decreased, as noted at the 3-wk and 3-mo follow-up examinations after injection. However, fat pad thickness remained unchanged. The center of pressure velocity during the loading response without inducing fat pad atrophy increased 3 mo after injection in the experimental group.
According to the results of the aforementioned studies, it seems that US-guided injection is an accurate and tolerable technique for treating PFS and plays a role in reducing PF thickness, risk of PF rupture and fat pad atrophy. Also, as an objective method, US can be used to evaluate PF thickness changes after different interventions.
In three studies (Kane et al. 2001; Tsai et al. 2006; Yucel et al. 2009 ), US-guided injection was compared with palpation-guided injection in the evaluation of PF thickness in patients with PFS. For example, Yucel et al. (2009) compared the efficacy of injections guided by scintigraphy, US and palpation in 27 patients with PFS. Patients were evaluated for pain intensity before the injections and at the last follow-up at 25.3 mo. There were significant improvements in PF thickness, fat pad thickness and pain intensity (on the visual analogue scale). Because of the increased accuracy and reduced repetition of injections, they suggested that injections should preferably be performed with US guidance. The remaining 7 of the 16 studies (Fabrikant and Park 2011; Genc et al. 2005; Gordon et al. 2012; Hammer et al. 2005; Kiritsi et al. 2010; Mahowald et al. 2011; Ragab and Othman 2012) investigated the efficacy of different interventions on PF thickness. Kiritsi et al. (2010) and documented the effect of LLLT on PFS using the US appearance of the aponeurosis and pain scores. Gordon et al. (2012) and Hammer et al. (2005) used US measurement of PF as an objective tool for evaluating shock wave therapy. Long-term US follow-up to evaluate the effect of injection on PF thickness in patients with PFS was performed by Genc et al. (2005) and Ragab and Othman (2012) . Also, Fabrikant and Park (2011) and Mahowald et al. (2011) used US to monitor PF thickness as a reliable measure in diagnosing and assessing the effect of different treatments in patients with PFS.
Despite differences in study sample sizes and selected interventions, all studies were classified as positive. The results indicate that US is clinically and objectively able to evaluate PF thickness in patients with PFS and to depict the morphologic changes related to PFS.
Diagnosis of plantar fasciitis using US
As outlined in Table 4 , 12 studies (Abdel-Wahab et al. 2008; Akfirat et al. 2003; Cheng et al. 2012; Kapoor et al. 2010; Karabay et al. 2007; Ozdemir et al. 2005; Sabir et al. 2005; Tsai et al. 2000a; Vohra et al. 2002; Walther et al. 2004; Wearing et al. 2007; Wu et al. 2011) compared PF thickness between patients with PFS and those without PFS using US in the diagnosis of PFS. Sabir et al. (2005) and Abdel-Wahab et al. (2008) compared US and MRI with respect to their accuracy and validity in the detection of PFS. PF and heel pad thickness and other signs were measured with both imaging modalities. Strong correlation was found on PF and fat pad thickness measurements between US and MRI. US sensitivity and specificity were reported to be 80.9% and 85.7%, respectively, in Sabir et al. (2005) . The statistical diagnostic accuracy of US was also reported to be 69.5% in the study carried out by AbdelWahab et al. (2008) . Akfirat et al. (2003) compared findings from US and plain radiography, and Kapoor et al. (2010) compared US with real elastography and MRI as imaging tool references in patients with PFS.
The results indicate that US can be considered a useful imaging modality in the diagnosis and management of PFS with an acceptable diagnostic accuracy comparable to that of MRI. In addition, compared with MRI and plain radiography, US is more cost effective, faster and easier to use, and more patient friendly and is non-invasive and radiation free.
The remaining 8 studies (Cheng et al. 2012; Karabay et al. 2007; Ozdemir et al. 2005; Tsai et al. 2000a; Vohra et al. 2002; Walther et al. 2004; Wearing et al. 2007; Wu et al. 2011) , used US to evaluate PF in patients with PFSs and subjects without PFS. For example, Wearing et al. (2007) compared US measures of PF thickness and radiographic measures of arch shape and regional loading of the foot during gait in 10 individuals with and without unilateral PF thickness. Meanwhile, static arch angle was determined from bilateral sagittal US and weightbearing lateral foot roentgenograms. Regional plantar loading was estimated from a pressure plate. The PF of the symptomatic limb was thicker than both the PF of Search results combined (n=128) Excluded (n=93) The US was used as both injection guide and assessment tool for evaluating PF thickness in patient with PFs.
The US was used as a tool for assessing PF thickness for evaluating effects of interventions in patient with PFs. (n=7)
The US was used as a guide for therapeutic intervention.
The role of US to identify PF thickness changes in patient with PFs compared with normal subjects. (n=12) Fig. 1 . Flow diagram of study selection. PF 5 plantar fascia; PFS 5 plantar fasciitis; US 5 ultrasound.
the asymptomatic limb and the PF of a matched control group limb. PF thickness was positively correlated with arch angle in symptomatic and asymptomatic feet and with peak regional loading of the midfoot in the symptomatic limb. All studies investigating US imaging reported that US appears to be a useful, reliable and valid tool for discriminating PF thickness in individuals with and without PFS. It can also be considered as an objective tool that provides sufficient and appropriate information for physicians to confirm the diagnosis of PFS.
Application of US as a guide for therapeutic intervention in patients with PFS.
As outlined in Table 5 , six studies (Buchbinder et al. 2002; Folman et al. 2005; Hyer et al. 2005; Ryan et al. 2009; Theodore et al. 2004; Vohra and Japour 2009) evaluated the effect of US as a guide for therapeutic interventions in patients with PFS.
For example, the success of US-guided ESWT for the treatment of recalcitrant PFS was evaluated by Hyer et al. (2005) , who assessed pain intensity using the visual analogue scale. After 124 d of follow-up, the results indicated that US-guided ESWT may be a useful tool in the treatment of chronic PFS. US guidance for fasciotomy of PF in patients with PFS was investigated by Vohra and Japour (2009) and Folman et al. (2005) . They concluded that US-guided PF release is a practical surgical procedure for the relief of chronic PFS, with fewer side effects because the surgeon is able to clearly visualize the PF. Ryan et al. (2009) reported that US guidance improved injection accuracy and significantly reduced pain intensity associated with chronic PFS. Buchbinder et al. (2002) , Hyer et al. (2005) , and Theodore et al. (2004) used US guidance to focus ESWT on the exact location of the pain.
These results indicate that US guidance allows direct real-time visualization and improves accuracy in the delivery of interventions in patients with PFS.
CONCLUSIONS
The purpose of this study was to systematically review published studies from 2000 to 2012 concerning the application of US in the assessment of PF in patients with PFS. There were wide variations in methodology, US equipment, sample size and other factors. The results indicate that US is an accurate, reliable and non-invasive imaging technique for assessing PF thickness, monitoring effects of different interventions and guiding therapeutic interventions in patients with PFS.
